Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD)

Part of paid clinical trials in Irvine, California.

Sponsor
Ray Therapeutics, Inc.
Study ID
NCT07502664
Status
Recruiting
Apply to this trial

Conditions

  • Geographic Atrophy From Age-related Macular Degeneration
  • Retinal Dystrophies
  • Retinitis Pigmentosa
  • Stargardt Disease
  • Stargardt Macular Dystrophy
  • X-linked Retinoschisis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The Vision Research and Assessment Institute (VRAI) was established with the purpose of serving as a testing facility for efficacy endpoints for patients with Low Vision. The mission of the VRAI is to enable the highest quality, standardized efficacy testing of patients with visual impairment. The VRAI facilitates the development and refinement of existing endpoints specifically for testing patients with Low Vision.

Key Dates

Start date
Feb 19, 2026
Status verified
Mar 2026
Primary completion
Feb 28, 2027
Completion
Feb 28, 2027

Study Design

Enrollment
25 participants (estimated)

Arms

  • Arm: Retinitis Pigmentosa
    Up to 25 patients with Retinitis Pigmentosa
  • Arm: Other Retinal Dystrophies
    Up to 25 patients with Other Retinal Dystrophies

Primary Outcome Measure

Operational feasibility of testing moderate to profound vision impaired patients with various retinal dystrophies on a battery of visual assessments [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vision Research and Assessment InstituteIrvineCalifornia92614
Reem Jaber, MS, CGC
[email protected]
949-264-3793

Find similar trials in Irvine, CA

By research site
Vision Research and Assessment Institute· Irvine, CA

Related Studies